COVID-19 Tedavisinde Famotidin Kullanımı

Objective: Famotidine is an H2 receptor antagonist (H2RA) and has been shown to have antiviral properties in in-vitro studies. Pantoprazole one of the proton pump inhibitors (PPI). In this study, it was aimed compare efficacy with treatment COVID-19.
 Material-method: Patients who were hospitalized given famotidine pantoprazole for at least 48 hours included study. Demographic, clinical laboratory findings patients analyzed retroprospectively from patient files. While primary endpoints need intensive care unit (ICU) death, secondary absence oxygen support, fever normal levels, length hospital stay.
 Results: A total 179 Covid-19 (85 (47.5%) famotidine, 94 (52.5%) pantoprazole) Demographic other symptoms except dyspnea similar both groups (p> 0.05). Dyspnea, chronic diseases, number steroids higher those (p The days fever, duration hospitalization, requiring support less